Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals PLC has purchased 213,205 ordinary shares on 17 August 2026 and 96,322 ordinary shares on 18 August 2026 as part of its $250 million share repurchase program. The purchases were made on the XLON trading venue, with prices ranging from 1,630.0000 pence to 1,657.0000 pence. The company intends to cancel these repurchased shares, and following these transactions, the total number of issued ordinary shares will be 208,795,427, with the total voting rights remaining the same.

Disclaimer*

UK 100

Latest directors dealings